NRD
ACHC icon

Nebula Research & Development’s Acadia Healthcare ACHC Stock Holding History

Nebula Research & Development’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-28,832
Closed -$654K – 11
2025
Q2 		$654K Sell
28,832
-11,698
-29% -$277K 0.06% 556
2025
Q1 		$1.23M Buy
+40,530
New +$1.54M 0.11% 304
2024
Q3 		– Sell
-7,123
Closed -$481K – 906
2024
Q2 		$481K Sell
7,123
-10,865
-60% -$759K 0.08% 442
2024
Q1 		$1.43M Buy
17,988
+14,016
+353% +$1.15M 0.31% 63
2023
Q4 		$309K Buy
+3,972
New +$294K 0.09% 422

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Nebula Research & Development's ACHC Position: Q3 2025 in Review

Nebula Research & Development sold out of Acadia Healthcare (ACHC) in Q3 2025, closing a stake of 28,832 shares — an estimated $654K sold.

Nebula Research & Development first reported a position in ACHC in Q4 2023 and held it in 5 quarters. The position peaked at $1.43M in Q1 2024. 270 funds tracked by Wall St. Rank hold ACHC as of Q3 2025.

  • Nebula Research & Development reported no remaining Acadia Healthcare position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 28,832 Acadia Healthcare shares in Q3 2025, an estimated $654K.
  • Nebula Research & Development first reported a position in Acadia Healthcare in Q4 2023 and held it in 5 quarters.
  • Nebula Research & Development's Acadia Healthcare position peaked at $1.43M in Q1 2024.
  • 270 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.